Logo image of MUX

MCEWEN INC (MUX) Stock Fundamental Analysis

USA - NYSE:MUX - US58039P3055 - Common Stock

15.55 USD
+0.85 (+5.78%)
Last: 9/26/2025, 8:14:17 PM
16 USD
+0.45 (+2.89%)
Pre-Market: 9/29/2025, 5:10:35 AM
Fundamental Rating

3

Taking everything into account, MUX scores 3 out of 10 in our fundamental rating. MUX was compared to 156 industry peers in the Metals & Mining industry. MUX may be in some trouble as it scores bad on both profitability and health. MUX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MUX had negative earnings in the past year.
MUX had a positive operating cash flow in the past year.
MUX had negative earnings in 4 of the past 5 years.
MUX had negative operating cash flow in 4 of the past 5 years.
MUX Yearly Net Income VS EBIT VS OCF VS FCFMUX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

MUX has a Return On Assets (-1.84%) which is in line with its industry peers.
MUX has a Return On Equity (-2.80%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.84%
ROE -2.8%
ROIC N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
MUX Yearly ROA, ROE, ROICMUX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

MUX has a better Gross Margin (21.71%) than 60.90% of its industry peers.
In the last couple of years the Gross Margin of MUX has grown nicely.
The Profit Margin and Operating Margin are not available for MUX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
MUX Yearly Profit, Operating, Gross MarginsMUX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MUX has been increased compared to 1 year ago.
MUX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MUX has an improved debt to assets ratio.
MUX Yearly Shares OutstandingMUX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MUX Yearly Total Debt VS Total AssetsMUX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.18, we must say that MUX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.18, MUX is not doing good in the industry: 88.46% of the companies in the same industry are doing better.
MUX has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.26, MUX is in line with its industry, outperforming 40.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -0.18
ROIC/WACCN/A
WACC8.74%
MUX Yearly LT Debt VS Equity VS FCFMUX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.35 indicates that MUX has no problem at all paying its short term obligations.
With a Current ratio value of 2.35, MUX perfoms like the industry average, outperforming 50.64% of the companies in the same industry.
MUX has a Quick Ratio of 1.82. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
MUX has a Quick ratio of 1.82. This is comparable to the rest of the industry: MUX outperforms 55.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 1.82
MUX Yearly Current Assets VS Current LiabilitesMUX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.16% over the past year.
Looking at the last year, MUX shows a decrease in Revenue. The Revenue has decreased by -9.48% in the last year.
Measured over the past years, MUX shows a quite strong growth in Revenue. The Revenue has been growing by 8.32% on average per year.
EPS 1Y (TTM)70.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.08%
Revenue 1Y (TTM)-9.48%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-1.63%

3.2 Future

Based on estimates for the next years, MUX will show a very strong growth in Earnings Per Share. The EPS will grow by 91.01% on average per year.
MUX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.62% yearly.
EPS Next Y119.96%
EPS Next 2Y71.76%
EPS Next 3Y91.01%
EPS Next 5YN/A
Revenue Next Year-15.65%
Revenue Next 2Y-4.77%
Revenue Next 3Y27.62%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MUX Yearly Revenue VS EstimatesMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
MUX Yearly EPS VS EstimatesMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 26.39 indicates a quite expensive valuation of MUX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MUX is on the same level as its industry peers.
MUX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 26.39
MUX Price Earnings VS Forward Price EarningsMUX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

MUX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.21
MUX Per share dataMUX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

MUX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MUX's earnings are expected to grow with 91.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.76%
EPS Next 3Y91.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MUX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MCEWEN INC

NYSE:MUX (9/26/2025, 8:14:17 PM)

Premarket: 16 +0.45 (+2.89%)

15.55

+0.85 (+5.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-03 2025-11-03
Inst Owners43.82%
Inst Owner Change16.54%
Ins Owners0.55%
Ins Owner Change0.81%
Market Cap841.41M
Analysts80
Price Target15.62 (0.45%)
Short Float %10.33%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)245.37%
Min EPS beat(2)-3.31%
Max EPS beat(2)494.06%
EPS beat(4)2
Avg EPS beat(4)89.43%
Min EPS beat(4)-197.03%
Max EPS beat(4)494.06%
EPS beat(8)4
Avg EPS beat(8)27.58%
EPS beat(12)6
Avg EPS beat(12)-30.55%
EPS beat(16)6
Avg EPS beat(16)-98.99%
Revenue beat(2)0
Avg Revenue beat(2)-7.62%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)-5.74%
Revenue beat(4)2
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)6.45%
Revenue beat(8)6
Avg Revenue beat(8)1.93%
Revenue beat(12)6
Avg Revenue beat(12)-3.64%
Revenue beat(16)6
Avg Revenue beat(16)-4.58%
PT rev (1m)0%
PT rev (3m)6.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1400%
EPS NY rev (1m)0%
EPS NY rev (3m)345%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.39
P/S 5
P/FCF N/A
P/OCF 41.02
P/B 1.74
P/tB 1.74
EV/EBITDA 37.21
EPS(TTM)-0.37
EYN/A
EPS(NY)0.59
Fwd EY3.79%
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)0.38
OCFY2.44%
SpS3.11
BVpS8.95
TBVpS8.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.84%
ROE -2.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.71%
FCFM N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 5.31
Cap/Depr 201.64%
Cap/Sales 34.53%
Interest Coverage N/A
Cash Conversion 86.56%
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 1.82
Altman-Z -0.18
F-Score5
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)153.99%
Cap/Depr(5y)131.29%
Cap/Sales(3y)27.62%
Cap/Sales(5y)24.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.08%
EPS Next Y119.96%
EPS Next 2Y71.76%
EPS Next 3Y91.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.48%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-1.63%
Revenue Next Year-15.65%
Revenue Next 2Y-4.77%
Revenue Next 3Y27.62%
Revenue Next 5YN/A
EBIT growth 1Y82.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.29%
EBIT Next 3Y101.59%
EBIT Next 5YN/A
FCF growth 1Y66.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.17%
OCF growth 3YN/A
OCF growth 5YN/A